Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Synthesis Market

DNA Synthesis Market Share

Report ID: GMI6000
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

DNA Synthesis Market Share

Major market players operating in the DNA synthesis market include :

Thermo Fisher Scientific, Inc.
Twist Bioscience
Bioneer Corporation
Eton Bioscience
LGC Biosearch Technologies
IBA GmbH
Eurofins Scientific
Integrated DNA Technologies, Inc.
Quintara Biosciences
GenScript Biotech Corporation
OriGene Technologies, Inc.
Eurogentec
ProMab Biotechnologies
BIOMATIK
ProteoGenix
BOSTER antibody
ELISA experts

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

In 2023, the global DNA synthesis market was valued at USD 4.1 billion and will grow at 19.5% CAGR from 2024 to 2032, attributed to rising demand for research in drug discovery and personalized medicine.

The oligonucleotide synthesis segment amassed 52.6% of the DNA synthesis market share in 2022, on account of the increasing utilization of oligonucleotide synthesis for synthetic biology.

North America DNA synthesis market held over 38.4% market share in 2022, attributed to the robust presence of leading industry players in the region.

Some of the leading DNA synthesis market players include Eton Bioscience, IBA GmbH, Integrated DNA Technologies, Inc., GenScript Biotech Corporation, LGC Biosearch Technologies, Eurofins Scientific, Quintara Biosciences, and OriGene Technologies, Inc., among others.